Highlights and Quick Summary
- Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending June 30, 2023 was -3.16% (a -132.78% decrease compared to previous quarter)
- Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -115.81%
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2022 was 10.15% (a 64.77% increase from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 6.16% (a -272.55% decrease from previous year)
- Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was -3.57% (a -123.63% decrease from previous year)
- Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending June 30, 2023 was 4.62% (a -58.27% decrease compared to previous quarter)
- Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -77.46% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
| 30 Jun '23 | 31 Mar '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| 4.62% | 11.07% | 10.15% | 20.5% |
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Selling, General and Administrative (SG&A) Expenses Growth of DURECT Corporation
Most recent Selling, General and Administrative (SG&A) Expenses Growthof DRRX including historical data for past 10 years.Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of DURECT Corporation
DURECT Corporation Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -3.16% | 9.64% | – | – | – |
| 2022 | -3.74% | 19.99% | 24.75% | 5.78% | 10.15% |
| 2021 | 32.26% | -5.63% | -5.06% | 2.91% | 6.16% |
| 2020 | -7.88% | -10.63% | 1.8% | -0.67% | -3.57% |
| 2019 | 9.55% | 33.69% | 16.41% | 8.14% | 15.11% |
| 2018 | 2.39% | -8.54% | -23.5% | 4.96% | -6.86% |
| 2017 | 16.63% | 3.12% | 27.46% | -0.62% | 11.33% |
| 2016 | -0.46% | -4.22% | 6.02% | 8.58% | 2.24% |
| 2015 | -5.79% | 4.13% | -4.42% | -16.15% | -5.85% |
| 2014 | -13.66% | -1.49% | -11.21% | 15.93% | -3.32% |
| 2013 | 20.12% | 8.51% | 5.28% | -11.55% | 5.05% |
| 2012 | -7.67% | -15.49% | – | – | -10.9% |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic